Activity Action
AssessmentEvaluate emetogenicity of planned chemotherapy.
For non-chemotherapy-naïve patients, review history of CINV control.
Evaluate and document nausea and vomiting using self-report wherever possible (usually in children 8 years of age and older) and by asking guardians where not possible (for children 2-7 years of age).
Possible center decision: Administer Pediatric Nausea Assessment Tool to children ≥ 4 years old QAM, QHS and whenever nausea is suspected.
PreventionPossible center decision: Possible center decision: Order antiemetics as per CPG.
Possible center decision: Adjust antiemetic prophylaxis in patients with history of poor CINV control as per CPG.
Possible center decision: Ondansetron is the preferred 5-HT3 antagonist for chemotherapy-naïve patients.
Treatment Possible center decision: Order lorazepam PRN as per CPG.
Possible center decision: In patients with breakthrough CINV, adjust scheduled antiemetics as per CPG.
Possible center decision: In patients with breakthrough or refractory CINV, offer child life or psychology services as per CPG.